Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James George Chopas currently holds 65,955 shares of Apellis Pharmaceuticals, Inc. (APLS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James George Chopas has been a net seller of APLS stock. They have purchased $0 and sold $236.6K worth of shares.
James George Chopas's most recent insider trade was on Jan 28, 2026, when they sold 16,150 shares at $0.00 per share.
James George Chopas serves as Executive at Apellis Pharmaceuticals, Inc. (APLS). They have executed 25 insider transactions totaling $236.6K over their tenure at the company.
James George Chopas holds the position of Executive at Apellis Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
James George Chopas has shown a selling trading pattern, with $0 in total purchases and $236.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James George Chopas was on Jan 16, 2024, when they purchased $801.3K worth of APLS shares. This transaction involved 12,086 shares at $66.30 per share.
James George Chopas currently owns 65,955 shares of Apellis Pharmaceuticals, Inc. (APLS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James George Chopas's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James George Chopas has 25 Form 4 filings on record as an insider at Apellis Pharmaceuticals, Inc..
Set alerts for James George Chopas and 40,000+ other insiders.